| ALK

Alertline

ALK Alertline

ALK's whistleblower hotline enables employees, business partners and other stakeholders to report any serious and sensitive concern in a confidential and anonymous manner.
Report a concern
If you wish to file a report, click on the link.

The ALK Alertline is a global hotline reporting system operated by an external and independent systems provider.

The system guarantees confidentiality and anonymity. ALK will ensure that there will be no discriminatory or retaliatory actions against an employee or stakeholder who raises a concern i good faith.

Scope

We encourage employees, suppliers, vendors, consultants or others with a work-related relationship with ALK to report serious and sensitive concerns about:

  • Breaches of applicable laws and regulations, and/or
  • Serious offences or other serious matters, and/or
  • The health and safety of our employees

if such actions are relevant for the ALK Group or an individual ALK company.

ALK Office Anonymous
Please note that this is not an emergency response call center. If you have any questions or inquiries regarding our products, please see contact details here:
Contact us
Procedure for raising a concern

If you are an employee of ALK, you are encouraged to discuss concerns first with your supervisor, manager or other appropriate personnel, such as local/global HR, local/global Finance, Corporate Affairs & Legal, or Information Security as an initial step in resolving concerns. 

Provide as much information as you can. It is also possible to upload files, copies of documents etc. All data provided will be subject to data privacy regulations. All reports received are evaluated and responded to and investigations are conducted if deemed necessary.

We kindly ask for your understanding that the ALK Alertline unfortunately cannot accept, process and, in particular, forward customer complaints or concerns.

Whistleblowing policy
For more information, please consult our Whistleblowing Policy
Last updated: 12.01.2024

Anti-corruption

ALK policy for anti-corruption

At ALK, we are committed to working against corruption in all its forms, including fraud and bribery. Thus, we do not accept corruption or bribery in connection with our business activities, regardless of whether these activities are being carried out by our employees or through a third party.

ac_policy_final.pdf

ALK policy for anti-corruption

Download
Last updated: 12.01.2024

Code of Conduct

Living our purpose and our cultural beliefs

ALK's Employee Code of Conduct outlines our expectations when it comes to professionalism, honesty and integrity. ALK’s managers are responsible for ensuring that each employee is is familiar with the code and its importance.
ALK_CodeOfConduct_UK_WEB_new_1.pdf

ALK's Code of Conduct

Download
Last updated: 22.03.2024

Synopses

Synopses

ALK sponsored clinical trial protocol information and results, regardless of outcome, are disclosed in publicly accessible clinical trial registries, for example EudraCT (clinicaltrialsregister.eu), clinicaltrials.gov or on this page.

Grass SLIT-tablet

GT-21 (EudraCT ID: 2009-011235-12)
GT-01
GT-02
GT-03
GT-04
GT-07
GT-08+ext (EudraCT ID: 2004-000083-27)
GT-09 (EudraCT ID: 2005-004962-18)
GT-10+ext (EudraCT ID: 2005-004724-39)
GT-12 (EudraCT ID: 2006-003415-46)
GT-11 (EudraCT ID: 2005-005402-22)
GT-14
GT-16 (EudraCT ID: 2006-005263-26)
GT-17 (EudraCT ID: 2006-004820-35)
GT-18 (EudraCT ID: 2007-006009-26)
GT-19 (EudraCT ID: 2008-003593-18)
P05238
P05239
P08067

HDM SLIT-tablet

MT-01
MT-02 (EudraCT ID: 2006-001795-20)
MT-03 (EudraCT ID: 2007-000402-67)
MT-04 (EudraCT ID: 2010-018621-19)
MT-06 (EudraCT ID: 2011-002277-38)
P001
P003 (EudraCT ID: 2012-001855-38)
P008

Ragweed SLIT-tablet

RT-01
P06081
P05233
P05234 (EudraCT ID: 2008-003864-20)
P05751

Adrenaline autoinjector

JX-A-03
Last updated: 12.01.2024

Status of applications

Status of applications

No applications have been received
Last updated: 12.01.2024

Data proctection officer

Data Protection Officer (DPO)

If you have any questions regarding your data protection rights or requests for access to your data etc., you are always welcome to contact our Data Protection Officer (DPO):
 
Bech-Bruun Advokatpartnerselskab
CVR nr.: 3853 8071
Gdanskgade 18
2150 Nordhavn
Denmark

Telephone: + 45 72 27 30 02
E-mail: dpo.alk@bechbruun.com
Secure E-mail Function via: https://dpo.bechbruun.com/alk
 
We encourage you to use the Secure E-mail Function if your inquiry or request contains sensitive or confidential information.
 

Last updated: 17.05.2018

Affiliate list

ALK affiliates

Denmark

ALK-Abello A/S (parent)

CVR no. 63 71 79 16

Bøge Alle 6-8

DK-2970 Hørsholm

Denmark

T: (+45) 4574 7576

 

ALK-Abello Nordic A/S

CVR no. 31 50 12 96

Bøge Alle 6-8

DK-2970 Hørsholm

Denmark

T: (+45) 3816 7070

F: (+45) 3816 7099

 

ALK e-com A/S

CVR no. DK 3926 6881 / DE815741125

Bøge Alle 6

DK-2970 Hørsholm

Denmark

Tel. (+49) 040 703845 402

 

Sweden

ALK Nordic A/S (branch)
Danmark Filial
Box 10073
434 21 Kungsbacka
Sweden

T: (+46) 300 185 45

F: (+46) 300 139 10

E-mail: infose@alk.net

 

Norway

ALK-Abelló Nordic (branch)
Filial av utlandsk aksjeselskap
Skårersletta 18
1473 Lørenskog
Norway

T: (+47) 99 44 60 40

F: (+47) 47 99 60 41

E-mail: infono@alk.net

 

Finland

ALK-Abello Nordic A/S (branch)

Linnoitustie 4

Espoo

02600

Finland

T: (+358) 9 5842 2120

Email: infofi@alk.net

 

United Kingdom

ALK-Abello Ltd.

1 Manor Park, Manor Farm Road

Reading, Berkshire, RG2 0NA

United Kingdom

T:(+44) 118 903 7940

F: (+44) 118 903 7941

 

France

ALK-Abello S.A.

Z. A. Les Vignes des Côtes, Varennes-en-Argonne

FR-55270

France

T : (+33) 3 29 80 71 62

F : (+33) 3 29 80 78 34

 

Germany

ALK-Abello Arzneimittel GmbH

Friesenweg 38

D-22763 Hamburg

Germany

T: (+49) 040 703845 0

Mail: info-deutschland@alk.net

 

Austria

ALK-Abelló Allergie-Service GmbH

Steingasse 6a

4020 Linz

Austria

Tel: +43 732 385372 -100

Mail: office_at@alk.net

 

Switzerland

ALK-Abelló AG

Richtistrasse 11

CH-8304 Wallisellen

Tel.: +41 44 908 21 00

 

Turkey

ALK İlaç ve Alerji Ürünleri Ticaret Anonim Şirketi

Sahrayıcedid Mah., Halk Sok., Gül Apt. No:42/A
34734 Kadıköy-Istanbul
Turkey
T: (+90) 216 477 71 71
F: (+90) 216 477 81 81

 

Netherlands

Transistorstraat 23-25
1322 CK Almere
Postbus 60022
1320 AA Almere
The Netherlands
T: (+31) 36 539 78 40
F: (+31) 36 539 78 41

 

Spain

ALK-Abello S.A.

Miguel Fleta 19
E-28037 Madrid
Spain
T: (+34) 91 32 76 100
F: (+34) 91 32 76 122

 

Italy

ALK-Abello S.p.A.

Via L. Settembrini 29
I-20020 Lainate MI
Italy
T: (+39) 02 93 7631
F: (+39) 02 93 763457

 

Poland

ALK-Abello sp. z o.o

AL. POKOJU 1
31-548 Krakow
Poland
T: (+48) 12 348 4000
F: (+48) 12 348 4098

 

USA

ALK-Abello, Inc.

1700 Royston Lane
Round Rock
Texas 78664
USA
T: +1 512 251 0037
F: +1 512 251 5882

 

ALK-Abello, Source Materials, Inc.

Spring Mills, Pennsylvania

USA

 

OKC Allergy Supplies Inc.

Oklahoma City, Oklahoma

USA

 

OKC Crystal Laboratory Inc.

Oklahoma City, Oklahoma

USA

 

Canada

ALK-Abello Pharmaceuticals, Inc.

# 35-151 Brunel Rd.
L4Z 2H6 Mississauga
Ontario
Canada
T: (+1) 905 290 9952
F: (+)1 905 290 9957

 

China

ALK-Abello A/S (branch)

Unit 1803, Midas Plaza, No. 1 Tai Yau Street, San Po Kong, Kowloon

Hong Kong, China

T: +852 2144 5218

F: +852 2144 5618

 

ALK Medical Consulting

Services Company Limited

Room 1202, Cross Region Times Building, No. 1777 North Zhongshan Road, Putuo District

Shanghai 200061

PR China

 

Slovakia

ALK Slovakia s.r.o.

Tomášikova 64 Lake Side Park, 10. floor,
831 04 Bratislava
Slovakia
T: (+421) 2 54 65 03 71
F: (+421) 2 54 65 03 73

 

Czech Republic

ALK Slovakia s.r.o. – odštěpný závod
Türkova 2319/5b
149 00 Praha 4 Chodov

Czech Republic
T: (+420) 233 312 907
F: (+420) 233 312 908

 

Jordan

ALK-Abello A/S (Branch)

V Business Centre – Office 205

Queen Rania Street, Bldg 112

P.O.Box 961753, Amman 11196

Jordan

T: (+962) 790 259 768

Last updated: 30.10.2023

Privacy values statement

ALK Privacy Values Statement

1. Respecting Privacy. In ALK, we respect the privacy and the rights of individuals in all areas of our business.
 
2. Individual rights, adequate information and access. Individuals need to be adequately informed about the processing of their personal data, their rights, and be allowed to access such data.
 
3. Care and diligence when handling requests and complaints. Any requests or complaints made by the individuals need to be handled with care and diligence.
 
4. Being fair and just in what we do. Processing of personal data not only needs to be legal, it also needs to be fair in the given circumstances and we need to be open about such practices.
 
5. Clearly defined purposes. Personal data may only be collected and used for clearly defined purposes.
 
6. Reasonable scope. The least amount of data sufficient for the given purposes must be collected, used and retained.
 
7. Quality of data is important. High quality/accuracy of data must be maintained and, as soon as no longer needed, data need to be deleted.
 
8. Reasonable protection. Personal data require reasonable protection and must be treated as confidential.
 
9. Life-cycle perspective. Full life-cycle protection, including transfers, need to be maintained.
 
10. Privacy is part of our DNA. Data protection should be embedded in the core settings and design of every product, process or service and not treated as an afterthought.
 
11. Sensitive data. Sensitive data merit special protection.
 
12. Special care in using technology in the decision-making process. Profiling and automated decision-making require very careful analysis before being allowed to be implemented.
 
13. International transfers. International transfers of personal data may be subject to specific requirements and limitations.
 
14. Privacy follows the data. Both internal and external transfers of personal data may be needed for our business operations, but the personal data must still be adequately protected.
 
15. Privacy standards when using third party processors. Entities processing data on our behalf must meet sufficient standards and appropriate contracts need to be in place.
 
16. Keeping track of what we do to protect your privacy. Our compliance efforts must be documented, so we can demonstrate where we stand on privacy.
 
17. Privacy is our joint responsibility. To protect personal data all departments and affiliates need to cooperate.
 
18. Being serious about possible breaches. Any breach must be reported immediately.
 
19. Keeping adequate records. Sufficient records of our operations must be kept. 
 
20. Compliance program. Audits, reviews, and assessments are required to ensure that a high level of data protection is being met.
 
21. Training and awareness. ALK staff processing personal data must be adequately trained.
 
22. Reporting misconducts. Reasonable efforts to prevent any breaches need to be taken and misconducts reported.
Last updated: 12.01.2024

Review of application

Review of application

Access to data may be provided following review of the application by a scientific review board including independent academic scientists and healthcare professionals.

The members of the scientific review board are:

Scientific Review Board Charter

Professor Stephen R Durham

Professor of Allergy and Respiratory Medicine

National Heart and Lung Institute

Imperial College London

Eric D Bateman MB ChB (UCT), MD (UCT), FRCP, DCH(UK)

Emeritus Professor

Division of Pulmonology & Department of Medicine

University of Cape Town

And

Knowledge Translation Unit, University of Cape Town Lung Institute

George Street, Mowbray 7700

Cape Town,  South Africa

John Villumsen (cand. Stat.)

Independent Statistical Consultant

StatAssist

Denmark

2085_lowres

The review process and role of the independent scientific review board is described in the scientific review board charter. Review criteria include general assessment, the patient’s perspective, a scientific perspective and a methodology assessment.

If access to data is granted, you will be given an estimated timeline for data sharing. An independent third party will analyse the data according to the statistical analysis plan and forward the results directly to you.

Applicants must publish the results as stated in the submitted publication plan.

Last updated: 12.01.2024

How to apply

How to apply

Research Proposal Form
Data Sharing Agreement

To apply for access to clinical trial data, please complete and submit the research proposal form including CVs and a statistical analysis plan to ClinicalTrials@alk.net.

After successful submission, you will receive a confirmation of receipt and an estimated timeline for handling of your application.

Please note that if you are granted access to data, you will need to sign the data sharing agreement.

If funding and/or approvals are required to perform the research e.g. approvals from ethics committees, it is the responsibility of the applicant to secure this.

Last updated: 12.01.2024
Subscribe to